Australia Stock Exchange release from NUHEARA : NUH Commences Clinical Trial with Pathway to FDA Submission
14/10/2021 23:38
Australia Stock Exchange release from NUHEARA NUH.AX : NUH Commences Clinical Trial with Pathway to FDA Submission
NUH — Nuheara News Story
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap